{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:12:18Z","timestamp":1793265138606,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ophtha.2011.07.027","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T21:02:10Z","timestamp":1313528530000},"page":"1916-1926","source":"Crossref","is-referenced-by-count":289,"title":["Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial"],"prefix":"10.1016","volume":"118","clinical-trial-number":[{"clinical-trial-number":"nct00132691","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"John H.","family":"Kempen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Altaweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet T.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Sugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.07.027_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01675857","article-title":"Causes of blindness in The Netherlands","volume":"52","author":"ten Doesschate","year":"1982","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib2","first-page":"13","article-title":"Vision Research\u2014A National Plan: 1983-1987","year":"1983"},{"key":"10.1016\/j.ophtha.2011.07.027_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","article-title":"International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease","volume":"103","author":"Bloch-Michel","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop","volume":"140","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","article-title":"Causes and frequency of blindness in patients with intraocular inflammatory disease","volume":"80","author":"Rothova","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000078612","article-title":"Uveitis: a potentially blinding disease","volume":"218","author":"Durrani","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2011.07.027_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.126.9.1191","article-title":"Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results","volume":"126","author":"Callanan","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.027_bib11","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(00)00466-8","article-title":"Fluocinolone acetonide sustained drug delivery device to treat severe uveitis","volume":"107","author":"Jaffe","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.027_bib12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2009.11.019","article-title":"The Multicenter Uveitis Steroid Treatment Trial: rationale, design, and baseline characteristics","volume":"149","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ophtha.2009.11.027","article-title":"Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis","volume":"117","author":"Pavesio","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.027_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0161-6420(96)30742-2","article-title":"Standardizing the measurement of visual acuity for clinical research studies: guidelines from the Eye Care Technology Forum","volume":"103","author":"Ferris","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.027_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0420.1999.770205.x","article-title":"Comparing significance and magnitude of glaucomatous visual field defects using the SITA and Full Threshold strategies","volume":"77","author":"Bengtsson","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2011.07.027_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: new outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2011.07.027_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00647843","article-title":"Criterion validity and reliability of the SF-36 in a population sample","volume":"3","author":"Jenkinson","year":"1994","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ophtha.2011.07.027_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.ophtha.2011.07.027_bib20","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2011.07.027_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0161-6420(01)00544-9","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial\u2014VIP report no. 1","volume":"108","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.027_bib22","series-title":"Data Monitoring Committees in Clinical Trials: A Practical Perspective","first-page":"126","article-title":"Statistical, Philosophical, and Ethical Issues in Data Monitoring","author":"Ellenberg","year":"2002"},{"key":"10.1016\/j.ophtha.2011.07.027_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.ophtha.2011.07.027_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.ophtha.2011.07.027_bib25","first-page":"85","article-title":"Statistical Analysis with Missing Data","author":"Little","year":"2002"},{"key":"10.1016\/j.ophtha.2011.07.027_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 measure of health-related quality of life","volume":"33","author":"Hays","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.ophtha.2011.07.027_bib27","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1167\/iovs.08-3225","article-title":"Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials","volume":"50","author":"Suner","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.07.027_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1477-7525-5-70","article-title":"Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer","volume":"5","author":"Pickard","year":"2007","journal-title":"Health Qual Life Outcomes [serial online]"},{"key":"10.1016\/j.ophtha.2011.07.027_bib29","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ophtha.2005.03.013","article-title":"Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis","volume":"112","author":"Jaffe","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.07.027_bib30","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajo.2008.06.019","article-title":"Ocular inflammation in Beh\u00e7et disease: incidence of ocular complications and of loss of visual acuity","volume":"146","author":"Kacmaz","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","article-title":"Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss","volume":"143","author":"Thorne","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib32","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/archopht.125.11.ecs70063","article-title":"Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants","volume":"125","author":"Goldstein","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"Da Silva","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2011.07.027_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/rheumatology\/kep096","article-title":"Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis","volume":"48","author":"Ravindran","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ophtha.2011.07.027_bib35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaci.2009.05.041","article-title":"Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers","volume":"124","author":"Wise","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2011.07.027_bib36","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2014reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011006816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011006816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T03:40:18Z","timestamp":1621050018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011006816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0161642011006816"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.027","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13270956.15750061","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.13270956.14653105","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.13270956.14625054","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}